Ser917

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser917 - IGSF9B (human)

Site Information
sQLTPLSsSQESYLP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 23115275

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	gastric cancer ( 1 )
Relevant cell line - cell type - tissue:	NUGC-2 (gastric) ( 1 )

References
1	Ren H (2008) CST Curation Set: 3790; Year: 2008; Biosample/Treatment: cell line, NUGC-2/serum starved; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info

References

1

Ren H (2008) CST Curation Set: 3790; Year: 2008; Biosample/Treatment: cell line, NUGC-2/serum starved; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.